Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$304.11 - $351.99 $1.31 Million - $1.51 Million
4,299 Added 259.29%
5,957 $2.06 Million
Q4 2023

Jan 08, 2024

BUY
$269.37 - $365.04 $38,519 - $52,200
143 Added 9.44%
1,658 $535,000
Q3 2023

Nov 17, 2023

SELL
$350.25 - $422.63 $367,412 - $443,338
-1,049 Reduced 40.91%
1,515 $543,000
Q2 2023

Jul 18, 2023

SELL
$359.49 - $486.4 $8,268 - $11,187
-23 Reduced 0.89%
2,564 $972,000
Q1 2023

Apr 07, 2023

SELL
$418.69 - $503.0 $373,890 - $449,179
-893 Reduced 25.66%
2,587 $1.24 Million
Q4 2022

Jan 17, 2023

SELL
$351.71 - $456.01 $116,064 - $150,483
-330 Reduced 8.66%
3,480 $1.46 Million
Q3 2022

Oct 14, 2022

BUY
$412.59 - $563.26 $124,602 - $170,104
302 Added 8.61%
3,810 $1.59 Million
Q2 2022

Jul 12, 2022

BUY
$463.67 - $597.16 $108,962 - $140,332
235 Added 7.18%
3,508 $1.74 Million
Q1 2022

Apr 07, 2022

BUY
$524.57 - $735.42 $450,605 - $631,725
859 Added 35.58%
3,273 $1.84 Million
Q4 2021

Jan 13, 2022

BUY
$708.84 - $794.68 $61,669 - $69,137
87 Added 3.74%
2,414 $1.82 Million
Q3 2021

Jan 13, 2022

SELL
$657.71 - $825.77 $95,367 - $119,736
-145 Reduced 5.87%
2,327 $1.74 Million
Q2 2021

Jul 20, 2021

BUY
$576.64 - $649.04 $238,728 - $268,702
414 Added 20.12%
2,472 $1.59 Million
Q1 2021

May 10, 2021

BUY
$547.01 - $662.35 $384,001 - $464,969
702 Added 51.77%
2,058 $1.18 Million
Q4 2020

Jan 08, 2021

BUY
$510.68 - $643.45 $108,264 - $136,411
212 Added 18.53%
1,356 $790,000
Q3 2020

Oct 15, 2020

BUY
$454.43 - $535.6 $15,905 - $18,746
35 Added 3.16%
1,144 $590,000
Q2 2020

Jul 07, 2020

BUY
$334.87 - $493.06 $371,370 - $546,803
1,109 New
1,109 $501,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.